% latex table generated in R 4.0.5 by xtable 1.8-4 package
% Thu May 13 16:40:01 2021
\begin{longtable}{lllllllrrrllrrrrllrrrrllrl}
  \hline
 & exposure.id & exposure.trait & outcome.id & outcome.trait & cf.id & cf.trait & r1.b & r1.se & r1.pval & r1.method & r1.selection & r1.moescore & r2.b & r2.se & r2.pval & r2.method & r2.selection & r2.moescore & r3.b & r3.se & r3.pval & r3.method & r3.selection & r3.moescore & cf.type \\ 
  \hline
1 & ebi-a-GCST003837 & Chronotype & ieu-a-976 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & -0.3496406 & 0.0387221 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  2 & ebi-a-GCST003837 & Chronotype & ieu-a-976 & Type 2 diabetes & prot-a-867 & Desmocollin-3 & -0.0246395 & 0.00450272 & 0.0000000445 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & 0.1935906 & 0.0449681 & 0.0000166937 & FE IVW & DF & 1.00 & confounder \\ 
  3 & ebi-a-GCST003837 & Chronotype & ieu-a-976 & Type 2 diabetes & ebi-a-GCST004941 & Dehydroepiandrosterone sulphate levels & -0.0539465 & 0.00837188 & 0.0000000001 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & -0.6098155 & 0.1241671 & 0.0000009050 & FE IVW & DF & 1.00 & confounder \\ 
  4 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ukb-a-132 & Treatment/medication code: aspirin & 0.6195661 & 0.13924107 & 0.0000086033 & FE IVW & DF & 0.67 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -1.4851811 & 0.0180978 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  5 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ubm-a-721 & IDP dMRI ProbtrackX L1 ifo l & -0.0378875 & 0.00645174 & 0.0000000043 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0977486 & 0.0206853 & 0.0000022955 & FE IVW & DF & 1.00 & confounder \\ 
  6 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.2737775 & 0.0346490 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  7 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ieu-a-815 & Systemic lupus erythematosus & -0.0069732 & 0.00012596 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0270934 & 0.0030550 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  8 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ukb-a-317 & Number of live births & -0.1057476 & 0.00858637 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.7621085 & 0.1236402 & 0.0000000007 & FE IVW & DF & 1.00 & confounder \\ 
  9 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ubm-a-810 & IDP dMRI ProbtrackX ICVF ptr r & 0.0229145 & 0.00102047 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0562187 & 0.0128442 & 0.0000120342 & FE IVW & DF & 1.00 & confounder \\ 
  10 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & prot-a-867 & Desmocollin-3 & -0.0246395 & 0.00450272 & 0.0000000445 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.1658106 & 0.0368420 & 0.0000067768 & FE IVW & DF & 1.00 & confounder \\ 
  11 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-479 & Propionylcarnitine & 0.0868602 & 0.02157118 & 0.0000565708 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 1.1484018 & 0.2591120 & 0.0000093334 & FE IVW & DF & 1.00 & confounder \\ 
  12 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-558 & 1-arachidonoylglycerophosphocholine* & 0.1017025 & 0.01801732 & 0.0000000165 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.9259287 & 0.2083082 & 0.0000087895 & FE IVW & DF & 1.00 & confounder \\ 
  13 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.3983203 & 0.0562217 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  14 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ukb-a-313 & Light smokers  at least 100 smokes in lifetime & 0.1496490 & 0.03276702 & 0.0000049461 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 1.4433012 & 0.0572680 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  15 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ukb-a-132 & Treatment/medication code: aspirin & 0.6195661 & 0.13924107 & 0.0000086033 & FE IVW & DF & 0.67 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -1.4853371 & 0.0185701 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  16 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ubm-a-721 & IDP dMRI ProbtrackX L1 ifo l & -0.0378875 & 0.00645174 & 0.0000000043 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0965829 & 0.0210460 & 0.0000044508 & FE IVW & DF & 1.00 & confounder \\ 
  17 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -0.2692494 & 0.0332254 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  18 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & met-a-616 & Alpha-hydroxyisovalerate & -0.0862465 & 0.01677617 & 0.0000002733 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.5501860 & 0.1411650 & 0.0000972032 & FE IVW & DF & 1.00 & confounder \\ 
  19 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ieu-a-815 & Systemic lupus erythematosus & -0.0069732 & 0.00012596 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0272730 & 0.0033036 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  20 & ieu-a-1087 & Chronotype & ieu-a-976 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & -0.3496406 & 0.0387221 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  21 & ieu-a-1087 & Chronotype & ieu-a-976 & Type 2 diabetes & prot-a-867 & Desmocollin-3 & -0.0246395 & 0.00450272 & 0.0000000445 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & 0.1935906 & 0.0449681 & 0.0000166937 & FE IVW & DF & 1.00 & confounder \\ 
  22 & ieu-a-1087 & Chronotype & ieu-a-976 & Type 2 diabetes & prot-a-1051 & Protein FAM3D & 0.0042707 & 0.00107403 & 0.0000699980 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & 0.0562833 & 0.0143027 & 0.0000831483 & FE IVW & DF & 1.00 & confounder \\ 
  23 & ieu-a-1087 & Chronotype & ieu-a-976 & Type 2 diabetes & ebi-a-GCST004941 & Dehydroepiandrosterone sulphate levels & -0.0508898 & 0.00815748 & 0.0000000004 & FE IVW & DF & 1.00 & 1.1075680 & 0.24783286 & 0.0000078582 & FE IVW & DF & 1.00 & -0.6098155 & 0.1241671 & 0.0000009050 & FE IVW & DF & 1.00 & confounder \\ 
  24 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ukb-a-132 & Treatment/medication code: aspirin & 0.6195661 & 0.13924107 & 0.0000086033 & FE IVW & DF & 0.67 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -1.4851811 & 0.0180978 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  25 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ubm-a-721 & IDP dMRI ProbtrackX L1 ifo l & -0.0378875 & 0.00645174 & 0.0000000043 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0977486 & 0.0206853 & 0.0000022955 & FE IVW & DF & 1.00 & confounder \\ 
  26 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.2737775 & 0.0346490 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  27 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & prot-a-1051 & Protein FAM3D & 0.0042707 & 0.00107403 & 0.0000699980 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0398342 & 0.0012512 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  28 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & ieu-a-815 & Systemic lupus erythematosus & -0.0069732 & 0.00012596 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0270934 & 0.0030550 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  29 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & ukb-a-317 & Number of live births & -0.1057476 & 0.00858637 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.7621085 & 0.1236402 & 0.0000000007 & FE IVW & DF & 1.00 & confounder \\ 
  30 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & ubm-a-810 & IDP dMRI ProbtrackX ICVF ptr r & 0.0229145 & 0.00102047 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0562187 & 0.0128442 & 0.0000120342 & FE IVW & DF & 1.00 & confounder \\ 
  31 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & prot-a-867 & Desmocollin-3 & -0.0246395 & 0.00450272 & 0.0000000445 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.1658106 & 0.0368420 & 0.0000067768 & FE IVW & DF & 1.00 & confounder \\ 
  32 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-479 & Propionylcarnitine & 0.0868602 & 0.02157118 & 0.0000565708 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 1.1484018 & 0.2591120 & 0.0000093334 & FE IVW & DF & 1.00 & confounder \\ 
  33 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-558 & 1-arachidonoylglycerophosphocholine* & 0.1017025 & 0.01801732 & 0.0000000165 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.9259287 & 0.2083082 & 0.0000087895 & FE IVW & DF & 1.00 & confounder \\ 
  34 & ieu-a-1087 & Chronotype & ieu-a-26 & Type 2 diabetes & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.3983203 & 0.0562217 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  35 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ukb-a-313 & Light smokers  at least 100 smokes in lifetime & 0.1496490 & 0.03276702 & 0.0000049461 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 1.4433012 & 0.0572680 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  36 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ukb-a-132 & Treatment/medication code: aspirin & 0.6195661 & 0.13924107 & 0.0000086033 & FE IVW & DF & 0.67 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -1.4853371 & 0.0185701 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  37 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ubm-a-721 & IDP dMRI ProbtrackX L1 ifo l & -0.0378875 & 0.00645174 & 0.0000000043 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0965829 & 0.0210460 & 0.0000044508 & FE IVW & DF & 1.00 & confounder \\ 
  38 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -0.2692494 & 0.0332254 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  39 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & prot-a-1051 & Protein FAM3D & 0.0042707 & 0.00107403 & 0.0000699980 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0398333 & 0.0012512 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  40 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & met-a-616 & Alpha-hydroxyisovalerate & -0.0862465 & 0.01677617 & 0.0000002733 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.5501860 & 0.1411650 & 0.0000972032 & FE IVW & DF & 1.00 & confounder \\ 
  41 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ieu-a-815 & Systemic lupus erythematosus & -0.0069732 & 0.00012596 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0272730 & 0.0033036 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  42 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.3301641 & 0.0845132 & 0.0000935818 & FE IVW & DF & 1.00 & intermediate \\ 
  43 & ebi-a-GCST003837 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.4676549 & 0.0884681 & 0.0000001249 & FE IVW & DF & 1.00 & intermediate \\ 
  44 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -0.4655984 & 0.0894890 & 0.0000001962 & FE IVW & DF & 1.00 & intermediate \\ 
  45 & ebi-a-GCST003837 & Chronotype & ieu-a-23 & Type 2 diabetes & ebi-a-GCST005185 & Fasting blood insulin & 0.1169709 & 0.02579680 & 0.0000057790 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 1.8134548 & 0.4479362 & 0.0000515542 & FE IVW & DF & 1.00 & intermediate \\ 
  46 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.3301641 & 0.0845132 & 0.0000935818 & FE IVW & DF & 1.00 & intermediate \\ 
  47 & ieu-a-1087 & Chronotype & ebi-a-GCST005047 & Type 2 diabetes & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & -0.4676549 & 0.0884681 & 0.0000001249 & FE IVW & DF & 1.00 & intermediate \\ 
  48 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & -0.4655984 & 0.0894890 & 0.0000001962 & FE IVW & DF & 1.00 & intermediate \\ 
  49 & ieu-a-1087 & Chronotype & ieu-a-23 & Type 2 diabetes & ebi-a-GCST005185 & Fasting blood insulin & 0.1169709 & 0.02579680 & 0.0000057790 & FE IVW & DF & 1.00 & 0.4815483 & 0.06501249 & 0.0000000000 & FE IVW & DF & 1.00 & 1.8134548 & 0.4479362 & 0.0000515542 & FE IVW & DF & 1.00 & intermediate \\ 
  50 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ukb-a-317 & Number of live births & -0.1057476 & 0.00858637 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.7621085 & 0.1236402 & 0.0000000007 & FE IVW & DF & 1.00 & confounder \\ 
  51 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ubm-a-810 & IDP dMRI ProbtrackX ICVF ptr r & 0.0229145 & 0.00102047 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0562187 & 0.0128442 & 0.0000120342 & FE IVW & DF & 1.00 & confounder \\ 
  52 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & prot-a-867 & Desmocollin-3 & -0.0246395 & 0.00450272 & 0.0000000445 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.1658106 & 0.0368420 & 0.0000067768 & FE IVW & DF & 1.00 & confounder \\ 
  53 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-479 & Propionylcarnitine & 0.0868602 & 0.02157118 & 0.0000565708 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 1.1484018 & 0.2591120 & 0.0000093334 & FE IVW & DF & 1.00 & confounder \\ 
  54 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & met-a-558 & 1-arachidonoylglycerophosphocholine* & 0.1017025 & 0.01801732 & 0.0000000165 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & 0.9259287 & 0.2083082 & 0.0000087895 & FE IVW & DF & 1.00 & confounder \\ 
  55 & ebi-a-GCST003837 & Chronotype & ieu-a-26 & Type 2 diabetes & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.8268623 & 0.09948527 & 0.0000000000 & FE IVW & DF & 1.00 & -0.3983203 & 0.0562217 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  56 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-14294 & Invitation to complete online 24-hour recall dietary questionnaire, acceptance & 0.0701217 & 0.01575812 & 0.0000085919 & FE IVW & HF & 0.76 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.5774520 & 0.0472905 & 0.0000000000 & FE IVW & DF & 1.00 & intermediate \\ 
  57 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4273542 & 0.0364694 & 0.0000000000 & FE IVW & DF & 0.77 & intermediate \\ 
  58 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-936 & Total fatty acids & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.6321611 & 0.0505625 & 0.0000000000 & FE IVW & Tophits & 0.74 & intermediate \\ 
  59 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4883015 & 0.0408582 & 0.0000000000 & FE IVW & HF & 0.70 & intermediate \\ 
  60 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4787694 & 0.0516725 & 0.0000000000 & FE IVW & DF & 0.74 & intermediate \\ 
  61 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-857 & Omega-7, omega-9 and saturated fatty acids & 0.5807043 & 0.09725314 & 0.0000000024 & FE IVW & HF & 0.69 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.7100436 & 0.0673274 & 0.0000000000 & FE IVW & HF & 0.68 & intermediate \\ 
  62 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4932014 & 0.0378862 & 0.0000000000 & FE IVW & HF & 0.86 & intermediate \\ 
  63 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-14294 & Invitation to complete online 24-hour recall dietary questionnaire, acceptance & 0.0701217 & 0.01575812 & 0.0000085919 & FE IVW & HF & 0.76 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.5774520 & 0.0472905 & 0.0000000000 & FE IVW & DF & 1.00 & intermediate \\ 
  64 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4273542 & 0.0364694 & 0.0000000000 & FE IVW & DF & 0.77 & intermediate \\ 
  65 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-936 & Total fatty acids & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.6321611 & 0.0505625 & 0.0000000000 & FE IVW & Tophits & 0.74 & intermediate \\ 
  66 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4883015 & 0.0408582 & 0.0000000000 & FE IVW & HF & 0.70 & intermediate \\ 
  67 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4787694 & 0.0516725 & 0.0000000000 & FE IVW & DF & 0.74 & intermediate \\ 
  68 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-857 & Omega-7, omega-9 and saturated fatty acids & 0.5807043 & 0.09725314 & 0.0000000024 & FE IVW & HF & 0.69 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.7100436 & 0.0673274 & 0.0000000000 & FE IVW & HF & 0.68 & intermediate \\ 
  69 & ieu-a-1087 & Chronotype & met-c-855 & Omega-3 fatty acids & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.4932014 & 0.0378862 & 0.0000000000 & FE IVW & HF & 0.86 & intermediate \\ 
  70 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-d-C3\_BRONCHUS\_LUNG & Malignant neoplasm of bronchus and lung & -1.7096574 & 0.05146071 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 6.1440397 & 1.3860619 & 0.0000093047 & FE IVW & DF & 1.00 & confounder \\ 
  71 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-2732 & Time from waking to first cigarette & 0.0351196 & 0.00351268 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0825386 & 0.0123033 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  72 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & prot-a-2760 & Sodium-coupled monocarboxylate transporter 1 & -0.0272016 & 0.00556728 & 0.0000010292 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.1607416 & 0.0121118 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  73 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & prot-a-1938 & C-type mannose receptor 2 & -0.0204453 & 0.00362687 & 0.0000000173 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0674982 & 0.0077556 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  74 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & prot-a-1537 & Interleukin-5 receptor subunit alpha & -0.0105796 & 0.00244320 & 0.0000148967 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0568474 & 0.0121055 & 0.0000026531 & FE IVW & DF & 1.00 & confounder \\ 
  75 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-a-558 & 1-arachidonoylglycerophosphocholine* & 0.1017025 & 0.01801732 & 0.0000000165 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 2.3707079 & 0.2311034 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  76 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ieu-a-815 & Systemic lupus erythematosus & -0.0069732 & 0.00012596 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0251126 & 0.0055720 & 0.0000065764 & FE IVW & DF & 1.00 & confounder \\ 
  77 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3357951 & 0.0672282 & 0.0000005888 & FE IVW & DF & 1.00 & confounder \\ 
  78 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-882 & Free cholesterol in large LDL & 0.0360723 & 0.00854054 & 0.0000240365 & FE IVW & HF & 0.77 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3754382 & 0.0732602 & 0.0000002980 & FE IVW & HF & 0.60 & reverse\_intermediate \\ 
  79 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.2367826 & 0.0504632 & 0.0000027031 & FE IVW & HF & 0.70 & reverse\_intermediate \\ 
  80 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.2914737 & 0.0581725 & 0.0000005429 & FE IVW & DF & 1.00 & collider \\ 
  81 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-936 & Total fatty acids & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3352782 & 0.0688615 & 0.0000011223 & FE IVW & DF & 1.00 & collider \\ 
  82 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.2147978 & 0.0510569 & 0.0000258750 & FE IVW & DF & 1.00 & collider \\ 
  83 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-931 & Phospholipids in small VLDL & 0.2322863 & 0.05815644 & 0.0000649233 & FE IVW & HF & 0.67 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.2516381 & 0.0516225 & 0.0000010904 & FE IVW & DF & 1.00 & collider \\ 
  84 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-c-857 & Omega-7, omega-9 and saturated fatty acids & 0.5807043 & 0.09725314 & 0.0000000024 & FE IVW & HF & 0.69 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.2708140 & 0.0676252 & 0.0000621135 & FE IVW & DF & 1.00 & collider \\ 
  85 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-a-679 & N2,N2-dimethylguanosine & -0.0566029 & 0.01025020 & 0.0000000335 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0139751 & 0.0029364 & 0.0000019433 & FE IVW & DF & 1.00 & collider \\ 
  86 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & met-a-433 & Levulinate (4-oxovalerate) & -0.0695406 & 0.00042506 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0213632 & 0.0043173 & 0.0000007488 & FE IVW & DF & 1.00 & collider \\ 
  87 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ebi-a-GCST005185 & Fasting blood insulin & 0.1169709 & 0.02579680 & 0.0000057790 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0819193 & 0.0176634 & 0.0000035212 & FE IVW & DF & 1.00 & collider \\ 
  88 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-266 & Current eye infection & -0.0266281 & 0.00593813 & 0.0000073168 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0020498 & 0.0002169 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  89 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-212 & Diagnoses - main ICD10: D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs & -0.0052601 & 0.00083386 & 0.0000000003 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0009572 & 0.0002245 & 0.0000200727 & FE IVW & DF & 1.00 & collider \\ 
  90 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-1761 & Diagnoses - secondary ICD10: J18.1 Lobar pneumonia, unspecified & -0.0012074 & 0.00022223 & 0.0000000553 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0005415 & 0.0000164 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  91 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-16174 & Sources of admission to hospital (recoded): Transfer within NHS provider: Surgical specialty & 0.0037020 & 0.00056282 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0004672 & 0.0000205 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  92 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-14315 & Treatment/medication code: nicorandil & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0007939 & 0.0000464 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  93 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-12762 & Operative procedures - secondary OPCS: S06.9 Unspecified other excision of lesion of skin & -0.0076851 & 0.00131035 & 0.0000000045 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0006103 & 0.0001162 & 0.0000001510 & FE IVW & DF & 1.00 & collider \\ 
  94 & ebi-a-GCST003837 & Chronotype & met-c-855 & Omega-3 fatty acids & ukb-b-11409 & Operative procedures - secondary OPCS: U08.1 Computed tomography of abdomen NEC & -0.0028017 & 0.00047901 & 0.0000000049 & FE IVW & DF & 1.00 & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.0005115 & 0.0000095 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  95 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6565234 & 0.0402218 & 0.0000000000 & FE IVW & Tophits & 0.80 & intermediate \\ 
  96 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-936 & Total fatty acids & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6585565 & 0.0435651 & 0.0000000000 & FE IVW & HF & 0.71 & intermediate \\ 
  97 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-930 & Concentration of small VLDL particles & 0.3349071 & 0.07554178 & 0.0000092757 & FE IVW & HF & 0.68 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.7931996 & 0.0476619 & 0.0000000000 & FE IVW & HF & 0.75 & intermediate \\ 
  98 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 1.0557567 & 0.0464482 & 0.0000000000 & FE IVW & HF & 0.77 & intermediate \\ 
  99 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-857 & Omega-7, omega-9 and saturated fatty acids & 0.5807043 & 0.09725314 & 0.0000000024 & FE IVW & HF & 0.69 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.3711763 & 0.0661713 & 0.0000000203 & FE IVW & DF & 1.00 & intermediate \\ 
  100 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.2147978 & 0.0510569 & 0.0000258750 & FE IVW & DF & 1.00 & intermediate \\ 
  101 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6565234 & 0.0402218 & 0.0000000000 & FE IVW & Tophits & 0.80 & intermediate \\ 
  102 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-936 & Total fatty acids & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6585565 & 0.0435651 & 0.0000000000 & FE IVW & HF & 0.71 & intermediate \\ 
  103 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-930 & Concentration of small VLDL particles & 0.3349071 & 0.07554178 & 0.0000092757 & FE IVW & HF & 0.68 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.7931996 & 0.0476619 & 0.0000000000 & FE IVW & HF & 0.75 & intermediate \\ 
  104 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-916 & Mono-unsaturated fatty acids & 0.4479559 & 0.10225098 & 0.0000118166 & FE IVW & HF & 0.65 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.3757108 & 0.0645705 & 0.0000000059 & FE IVW & DF & 1.00 & intermediate \\ 
  105 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 1.0557567 & 0.0464482 & 0.0000000000 & FE IVW & HF & 0.77 & intermediate \\ 
  106 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-857 & Omega-7, omega-9 and saturated fatty acids & 0.5807043 & 0.09725314 & 0.0000000024 & FE IVW & HF & 0.69 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.3711763 & 0.0661713 & 0.0000000203 & FE IVW & DF & 1.00 & intermediate \\ 
  107 & ieu-a-1087 & Chronotype & met-c-934 & Serum total triglycerides & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.2147978 & 0.0510569 & 0.0000258750 & FE IVW & DF & 1.00 & intermediate \\ 
  108 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-d-1418\_1 & Milk type used: Full cream & -2.4767945 & 0.21334485 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -3.3653389 & 0.7935877 & 0.0000222860 & FE IVW & DF & 1.00 & confounder \\ 
  109 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-b-6811 & Time spent outdoors in winter & 0.8579572 & 0.01304579 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.6736045 & 0.0358827 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  110 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-a-313 & Light smokers  at least 100 smokes in lifetime & 0.1496490 & 0.03276702 & 0.0000049461 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.4651843 & 0.1104999 & 0.0000255580 & FE IVW & DF & 1.00 & confounder \\ 
  111 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-a-243 & Frequency of unenthusiasm / disinterest in last 2 weeks & 0.4660077 & 0.07346513 & 0.0000000002 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.6650406 & 0.0432015 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  112 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ubm-a-1620 & NET100 0464 & 0.0569599 & 0.00838945 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.0795052 & 0.0123339 & 0.0000000001 & FE IVW & DF & 1.00 & confounder \\ 
  113 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-983 & ERO1-like protein beta & -0.0213182 & 0.00314211 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0282439 & 0.0052270 & 0.0000000654 & FE IVW & DF & 1.00 & confounder \\ 
  114 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-804 & Beta-defensin 1 & -0.0104155 & 0.00129523 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0047817 & 0.0006809 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  115 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-467 & T-cell surface glycoprotein CD8 beta chain & -0.0439498 & 0.00449747 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0409087 & 0.0038686 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  116 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-2760 & Sodium-coupled monocarboxylate transporter 1 & -0.0272016 & 0.00556728 & 0.0000010292 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.2352604 & 0.0408773 & 0.0000000086 & FE IVW & DF & 1.00 & confounder \\ 
  117 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-412 & Cerebral cavernous malformations 2 protein & -0.0375486 & 0.00392383 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0364771 & 0.0055084 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  118 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-2324 & DNA-directed RNA polymerases I and III subunit RPAC1 & -0.0365710 & 0.00887990 & 0.0000381508 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0348431 & 0.0044970 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  119 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-2018 & Kinetochore protein NDC80 homolog & -0.0336651 & 0.00406517 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0426415 & 0.0033820 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  120 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-1402 & Intercellular adhesion molecule 5 & 0.0038133 & 0.00072987 & 0.0000001745 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.0235871 & 0.0055858 & 0.0000241413 & FE IVW & DF & 1.00 & confounder \\ 
  121 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & prot-a-1126 & Receptor-type tyrosine-protein kinase FLT3 & -0.0308118 & 0.00752403 & 0.0000421941 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0348126 & 0.0037393 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  122 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.2256209 & 0.0549322 & 0.0000400380 & FE IVW & DF & 1.00 & confounder \\ 
  123 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-b-1668 & Diagnoses - main ICD10: I25.1 Atherosclerotic heart disease & 0.4630838 & 0.10316709 & 0.0000071667 & FE IVW & DF + HF & 0.74 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0071584 & 0.0008779 & 0.0000000000 & FE IVW & HF & 0.85 & reverse\_intermediate \\ 
  124 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-a-132 & Treatment/medication code: aspirin & 0.6195661 & 0.13924107 & 0.0000086033 & FE IVW & DF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0188309 & 0.0030411 & 0.0000000006 & FE IVW & HF & 0.79 & reverse\_intermediate \\ 
  125 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ebi-a-GCST005068 & LDL cholesterol & 0.0291401 & 0.00688339 & 0.0000230193 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.3625216 & 0.0846121 & 0.0000183138 & FE IVW & HF & 0.69 & reverse\_intermediate \\ 
  126 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.4491634 & 0.0839881 & 0.0000000890 & FE IVW & HF & 0.67 & reverse\_intermediate \\ 
  127 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-b-11209 & Diagnoses - secondary ICD10: R79.8 Other specified abnormal findings of blood chemistry & 0.0031014 & 0.00074452 & 0.0000310481 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0013285 & 0.0003396 & 0.0000916460 & FE IVW & DF & 1.00 & collider \\ 
  128 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ukb-b-10586 & Treatment/medication code: calcichew 1.25g chewable tablet & -0.0022920 & 0.00048566 & 0.0000023664 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.0006274 & 0.0000447 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  129 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-931 & Phospholipids in small VLDL & 0.2322863 & 0.05815644 & 0.0000649233 & FE IVW & HF & 0.67 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.9009892 & 0.0364703 & 0.0000000000 & FE IVW & DF + HF & 0.62 & collider \\ 
  130 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-890 & Concentration of large VLDL particles & 0.3416673 & 0.07778486 & 0.0000112073 & FE IVW & HF & 0.72 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.7992086 & 0.0469517 & 0.0000000000 & FE IVW & DF & 0.77 & collider \\ 
  131 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.4883015 & 0.0408582 & 0.0000000000 & FE IVW & HF & 0.70 & collider \\ 
  132 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-a-730 & X-14632 & 0.0920730 & 0.01436327 & 0.0000000001 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.0672367 & 0.0120146 & 0.0000000219 & FE IVW & DF & 1.00 & collider \\ 
  133 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & met-a-433 & Levulinate (4-oxovalerate) & -0.0695406 & 0.00042506 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.0354521 & 0.0087906 & 0.0000550757 & FE IVW & DF & 1.00 & collider \\ 
  134 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.7774729 & 0.0507461 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  135 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ebi-a-GCST005047 & Type 2 diabetes & 0.4708763 & 0.06004154 & 0.0000000000 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & -0.3301641 & 0.0845132 & 0.0000935818 & FE IVW & DF & 1.00 & collider \\ 
  136 & ebi-a-GCST003837 & Chronotype & met-c-934 & Serum total triglycerides & ebi-a-GCST002216 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.7246308 & 0.0515663 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  137 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-930 & Concentration of small VLDL particles & 0.3349071 & 0.07554178 & 0.0000092757 & FE IVW & HF & 0.68 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.7482545 & 0.0397570 & 0.0000000000 & FE IVW & DF + HF & 0.69 & intermediate \\ 
  138 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-912 & Total lipids in medium VLDL & 0.3753972 & 0.09087639 & 0.0000361417 & FE IVW & DF & 0.71 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.7252672 & 0.0552326 & 0.0000000000 & FE IVW & HF & 0.70 & intermediate \\ 
  139 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.3352782 & 0.0688615 & 0.0000011223 & FE IVW & DF & 1.00 & intermediate \\ 
  140 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6389760 & 0.0336639 & 0.0000000000 & FE IVW & DF + HF & 0.86 & intermediate \\ 
  141 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST002216 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6752913 & 0.0401346 & 0.0000000000 & FE IVW & DF + HF & 0.89 & intermediate \\ 
  142 & ieu-a-1087 & Chronotype & met-c-936 & Total fatty acids & met-c-930 & Concentration of small VLDL particles & 0.3349071 & 0.07554178 & 0.0000092757 & FE IVW & HF & 0.68 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.7482545 & 0.0397570 & 0.0000000000 & FE IVW & DF + HF & 0.69 & intermediate \\ 
  143 & ieu-a-1087 & Chronotype & met-c-936 & Total fatty acids & met-c-912 & Total lipids in medium VLDL & 0.3753972 & 0.09087639 & 0.0000361417 & FE IVW & DF & 0.71 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.7252672 & 0.0552326 & 0.0000000000 & FE IVW & HF & 0.70 & intermediate \\ 
  144 & ieu-a-1087 & Chronotype & met-c-936 & Total fatty acids & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.3352782 & 0.0688615 & 0.0000011223 & FE IVW & DF & 1.00 & intermediate \\ 
  145 & ieu-a-1087 & Chronotype & met-c-936 & Total fatty acids & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6389760 & 0.0336639 & 0.0000000000 & FE IVW & DF + HF & 0.86 & intermediate \\ 
  146 & ieu-a-1087 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST002216 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6752913 & 0.0401346 & 0.0000000000 & FE IVW & DF + HF & 0.89 & intermediate \\ 
  147 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ukb-b-6811 & Time spent outdoors in winter & 0.8579572 & 0.01304579 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & -0.5808205 & 0.1308712 & 0.0000090752 & FE IVW & DF & 1.00 & confounder \\ 
  148 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & prot-a-2760 & Sodium-coupled monocarboxylate transporter 1 & -0.0272016 & 0.00556728 & 0.0000010292 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & -0.1885065 & 0.0461323 & 0.0000438466 & FE IVW & DF & 1.00 & confounder \\ 
  149 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & prot-a-2018 & Kinetochore protein NDC80 homolog & -0.0336651 & 0.00406517 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.0402356 & 0.0012969 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  150 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & prot-a-1126 & Receptor-type tyrosine-protein kinase FLT3 & -0.0308118 & 0.00752403 & 0.0000421941 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.0384778 & 0.0078217 & 0.0000008683 & FE IVW & DF & 1.00 & confounder \\ 
  151 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ieu-a-1049 & Iron & 0.0149559 & 0.00305914 & 0.0000010139 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.0854872 & 0.0123910 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  152 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST005068 & LDL cholesterol & 0.0291401 & 0.00688339 & 0.0000230193 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.3006063 & 0.0494907 & 0.0000000012 & FE IVW & HF & 0.62 & confounder \\ 
  153 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.5201827 & 0.0789626 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  154 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ukb-b-1668 & Diagnoses - main ICD10: I25.1 Atherosclerotic heart disease & 0.4630838 & 0.10316709 & 0.0000071667 & FE IVW & DF + HF & 0.74 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.0085202 & 0.0008152 & 0.0000000000 & FE IVW & DF + HF & 0.76 & reverse\_intermediate \\ 
  155 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-882 & Free cholesterol in large LDL & 0.0360723 & 0.00854054 & 0.0000240365 & FE IVW & HF & 0.77 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.4629306 & 0.0231602 & 0.0000000000 & FE IVW & DF + HF & 0.70 & reverse\_intermediate \\ 
  156 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-870 & Concentration of IDL particles & 0.0293321 & 0.00734575 & 0.0000652255 & FE IVW & HF & 0.85 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.9580172 & 0.0548256 & 0.0000000000 & FE IVW & Tophits & 0.66 & reverse\_intermediate \\ 
  157 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST005065 & Cholesterol, total & 0.0313299 & 0.00256682 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.4867309 & 0.0867053 & 0.0000000198 & FE IVW & HF & 0.64 & reverse\_intermediate \\ 
  158 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-956 & Triglycerides in very small VLDL & 0.2756444 & 0.06201072 & 0.0000087848 & FE IVW & HF & 0.67 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.8563650 & 0.0663612 & 0.0000000000 & FE IVW & HF & 0.64 & collider \\ 
  159 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-934 & Serum total triglycerides & 0.3627431 & 0.06430366 & 0.0000000169 & FE IVW & HF & 0.73 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6585565 & 0.0435651 & 0.0000000000 & FE IVW & HF & 0.71 & collider \\ 
  160 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6321611 & 0.0505625 & 0.0000000000 & FE IVW & Tophits & 0.74 & collider \\ 
  161 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-a-743 & Tryptophan betaine & 0.4708220 & 0.02374186 & 0.0000000000 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.1171120 & 0.0286547 & 0.0000436985 & FE IVW & DF & 1.00 & collider \\ 
  162 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-a-730 & X-14632 & 0.0920730 & 0.01436327 & 0.0000000001 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & -0.0578212 & 0.0116929 & 0.0000007615 & FE IVW & DF & 1.00 & collider \\ 
  163 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & met-a-630 & X-12524 & -0.0657029 & 0.01098834 & 0.0000000022 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.0342704 & 0.0055986 & 0.0000000009 & FE IVW & DF & 1.00 & collider \\ 
  164 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ieu-a-302 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6621998 & 0.0512558 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  165 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST005185 & Fasting blood insulin & 0.1169709 & 0.02579680 & 0.0000057790 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & -0.0744977 & 0.0172678 & 0.0000160149 & FE IVW & DF & 1.00 & collider \\ 
  166 & ebi-a-GCST003837 & Chronotype & met-c-936 & Total fatty acids & ebi-a-GCST002216 & Triglycerides & -0.1639666 & 0.02769015 & 0.0000000032 & FE IVW & DF & 1.00 & 0.6218546 & 0.10791044 & 0.0000000083 & FE IVW & DF + HF & 0.67 & 0.6621998 & 0.0512558 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  167 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & ubm-a-458 & IDP dMRI TBSS L3 Anterior corona radiata R & 0.3172729 & 0.05275580 & 0.0000000018 & FE IVW & DF + HF & 0.64 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0013157 & 0.0003262 & 0.0000551081 & FE IVW & DF & 1.00 & intermediate \\ 
  168 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0007939 & 0.0000464 & 0.0000000000 & FE IVW & DF & 1.00 & intermediate \\ 
  169 & ieu-a-1087 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & ubm-a-458 & IDP dMRI TBSS L3 Anterior corona radiata R & 0.3172729 & 0.05275580 & 0.0000000018 & FE IVW & DF + HF & 0.64 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0013157 & 0.0003262 & 0.0000551081 & FE IVW & DF & 1.00 & intermediate \\ 
  170 & ieu-a-1087 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & met-c-855 & Omega-3 fatty acids & 0.6280975 & 0.08525006 & 0.0000000000 & FE IVW & HF & 0.68 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0007939 & 0.0000464 & 0.0000000000 & FE IVW & DF & 1.00 & intermediate \\ 
  171 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & ukb-d-1418\_1 & Milk type used: Full cream & -2.4767945 & 0.21334485 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0137126 & 0.0016078 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  172 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & ubm-a-481 & IDP dMRI TBSS L3 Uncinate fasciculus L & -0.0574732 & 0.00661387 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0009333 & 0.0000945 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  173 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & prot-a-3193 & Vascular cell adhesion protein 1 & 0.0234217 & 0.00212550 & 0.0000000000 & FE IVW & DF & 1.00 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0010210 & 0.0002277 & 0.0000073288 & FE IVW & DF & 1.00 & confounder \\ 
  174 & ebi-a-GCST003837 & Chronotype & ukb-b-14315 & Treatment/medication code: nicorandil & met-a-479 & Propionylcarnitine & 0.0868602 & 0.02157118 & 0.0000565708 & FE IVW & DF & 1.00 & -0.0074871 & 0.00098305 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0044171 & 0.0007395 & 0.0000000023 & FE IVW & DF & 1.00 & confounder \\ 
  175 & ukb-a-11 & Morning/evening person (chronotype) & ieu-a-808 & Bipolar disorder & ieu-a-1132 & ER+ Breast cancer (Oncoarray) & 0.3187290 & 0.07373245 & 0.0000154077 & FE IVW & Tophits & 0.78 & 0.1716641 & 0.02498617 & 0.0000000000 & FE IVW & DF & 1.00 & 0.4220721 & 0.0980997 & 0.0000168895 & FE IVW & DF & 1.00 & intermediate \\ 
  176 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-b-4256 & Lifetime number of sexual partners & 0.0749294 & 0.01270717 & 0.0000000037 & FE IVW & Tophits & 0.74 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0901595 & 0.0217969 & 0.0000352898 & FE IVW & HF & 0.76 & intermediate \\ 
  177 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-d-XIII\_MUSCULOSKELET & Diseases of the musculoskeletal system and connective tissue & -0.7888033 & 0.18482238 & 0.0000197322 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & -0.6341814 & 0.1339647 & 0.0000022020 & FE IVW & DF & 1.00 & confounder \\ 
  178 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-d-C3\_BRONCHUS\_LUNG & Malignant neoplasm of bronchus and lung & -0.9029569 & 0.10142394 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & -2.6577700 & 0.4382811 & 0.0000000013 & FE IVW & DF & 1.00 & confounder \\ 
  179 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-d-22704\_irnt & Home location - north co-ordinate (rounded) & 0.1846649 & 0.02228388 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.3226060 & 0.0812175 & 0.0000712348 & FE IVW & DF & 1.00 & confounder \\ 
  180 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-d-1418\_1 & Milk type used: Full cream & 2.1601818 & 0.04066500 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 1.9774341 & 0.3349051 & 0.0000000035 & FE IVW & DF & 1.00 & confounder \\ 
  181 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-b-9508 & Coffee consumed & 0.0796065 & 0.01100341 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & -0.3711071 & 0.0681693 & 0.0000000521 & FE IVW & DF & 1.00 & confounder \\ 
  182 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-b-8988 & Diagnoses - main ICD10: K80.1 Calculus of gallbladder with other cholecystitis & -0.7012149 & 0.10148170 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.3500408 & 0.0713461 & 0.0000009284 & FE IVW & DF & 1.00 & confounder \\ 
  183 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-a-239 & Loneliness  isolation & 0.6716411 & 0.08178146 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.5406723 & 0.0922616 & 0.0000000046 & FE IVW & DF & 1.00 & confounder \\ 
  184 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & prot-a-3191 & Valine--tRNA ligase & -0.0019988 & 0.00042057 & 0.0000020086 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0049384 & 0.0000708 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  185 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & prot-a-1606 & Anosmin-1 & -0.0309201 & 0.00329519 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0146585 & 0.0010388 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  186 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & prot-a-1586 & Inter-alpha-trypsin inhibitor heavy chain H1 & 0.0050789 & 0.00085781 & 0.0000000032 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0041387 & 0.0003621 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  187 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ieu-a-99 & Hip circumference & -0.1317877 & 0.02926625 & 0.0000066981 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & -0.1392537 & 0.0229463 & 0.0000000013 & FE IVW & DF & 1.00 & confounder \\ 
  188 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & ukb-b-15869 & Types of physical activity in last 4 weeks: None of the above & 0.9027645 & 0.05706415 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0552171 & 0.0100656 & 0.0000000412 & FE IVW & Tophits & 0.76 & reverse\_intermediate \\ 
  189 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-5174 & Average weekly beer plus cider intake & prot-a-3137 & Ubiquitin-conjugating enzyme E2 G2 & -0.0197110 & 0.00350925 & 0.0000000194 & FE IVW & DF & 1.00 & 0.0843970 & 0.01275066 & 0.0000000000 & FE IVW & HF & 0.71 & -0.5931408 & 0.0528368 & 0.0000000000 & FE IVW & DF + HF & 0.73 & reverse\_intermediate \\ 
  190 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-b-4256 & Lifetime number of sexual partners & 0.0749294 & 0.01270717 & 0.0000000037 & FE IVW & Tophits & 0.74 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.1246924 & 0.0198071 & 0.0000000003 & FE IVW & Tophits & 0.71 & intermediate \\ 
  191 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-d-680\_1 & Own or rent accommodation lived in: Own outright (by you or someone in your household) & -0.5823462 & 0.09172767 & 0.0000000002 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & -1.0558809 & 0.0668270 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  192 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-b-323 & Illnesses of father: Alzheimer's disease/dementia & -0.5549692 & 0.07059307 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & -0.2128167 & 0.0517757 & 0.0000395047 & FE IVW & DF & 1.00 & confounder \\ 
  193 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-a-401 & Qualifications: CSEs or equivalent & 0.7547611 & 0.10537512 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.4858590 & 0.0563070 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  194 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ubm-a-248 & IDP dMRI TBSS MD Splenium of corpus callosum & 0.0131288 & 0.00316940 & 0.0000343762 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0171472 & 0.0032523 & 0.0000001347 & FE IVW & DF & 1.00 & confounder \\ 
  195 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & prot-a-972 & Endoplasmic reticulum aminopeptidase 2 & -0.0060490 & 0.00042392 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0156055 & 0.0017279 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  196 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & prot-a-540 & Chitinase-3-like protein 1 & -0.0040340 & 0.00058055 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & -0.0034265 & 0.0005584 & 0.0000000008 & FE IVW & DF & 1.00 & confounder \\ 
  197 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & prot-a-2820 & Serine protease inhibitor Kazal-type 6 & -0.0033831 & 0.00054809 & 0.0000000007 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0045976 & 0.0006324 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  198 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & met-a-500 & 3-dehydrocarnitine* & -0.1021130 & 0.01654979 & 0.0000000007 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & -0.1297254 & 0.0193404 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  199 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-d-M13\_POLYARTHROPATHIES & \#Polyarthropathies & -0.3219046 & 0.01322262 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0133763 & 0.0034147 & 0.0000895538 & FE IVW & Tophits & 0.71 & reverse\_intermediate \\ 
  200 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-b-15869 & Types of physical activity in last 4 weeks: None of the above & 0.9027645 & 0.05706415 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0885536 & 0.0079073 & 0.0000000000 & FE IVW & Tophits & 0.87 & reverse\_intermediate \\ 
  201 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-b-10903 & Non-cancer illness code, self-reported: endometriosis & -0.4213805 & 0.06900797 & 0.0000000010 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0125080 & 0.0029939 & 0.0000294381 & FE IVW & Tophits & 0.81 & reverse\_intermediate \\ 
  202 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-a-401 & Qualifications: CSEs or equivalent & 0.7547611 & 0.10537512 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.0704325 & 0.0112570 & 0.0000000004 & FE IVW & HF & 0.78 & reverse\_intermediate \\ 
  203 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ukb-a-28 & Average weekly beer plus cider intake & 0.5135951 & 0.07380747 & 0.0000000000 & FE IVW & HF & 0.71 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 0.1423873 & 0.0293913 & 0.0000012691 & FE IVW & HF & 0.79 & reverse\_intermediate \\ 
  204 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ubm-a-159 & IDP T1 FAST ROIs L cerebellum IX & -0.0558601 & 0.00659406 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & -0.7782674 & 0.1760427 & 0.0000098290 & FE IVW & Tophits & 0.64 & reverse\_intermediate \\ 
  205 & ukb-a-11 & Morning/evening person (chronotype) & ukb-b-929 & Frequency of tiredness / lethargy in last 2 weeks & ebi-a-GCST005522 & Narcolepsy & -1.6414641 & 0.19762599 & 0.0000000000 & FE IVW & DF & 1.00 & 0.0670919 & 0.01195506 & 0.0000000200 & FE IVW & Tophits & 0.72 & 2.5471749 & 0.0471367 & 0.0000000000 & FE IVW & DF & 1.00 & collider \\ 
  206 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-b-9592 & Operative procedures - main OPCS: K63.3 Angiocardiography of left side of heart NEC & -0.7598259 & 0.03378288 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.0342838 & 0.0073341 & 0.0000029458 & FE IVW & DF & 1.00 & confounder \\ 
  207 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-b-6266 & Operation code: cataract extraction/lens implant & 0.7747744 & 0.14121480 & 0.0000000410 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.1720481 & 0.0259508 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  208 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-b-323 & Illnesses of father: Alzheimer's disease/dementia & -0.5549692 & 0.07059307 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & 0.1860604 & 0.0283836 & 0.0000000001 & FE IVW & DF & 1.00 & confounder \\ 
  209 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-b-2205 & Diagnoses - secondary ICD10: Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system & -0.5241045 & 0.03391442 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.0263429 & 0.0033237 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  210 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-b-18189 & Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia') & -0.5447127 & 0.03946092 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.3577190 & 0.0452832 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  211 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-a-530 & Diagnoses - main ICD10: H26 Other cataract & 0.8120748 & 0.03930053 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.1473617 & 0.0083316 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  212 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-a-511 & Number of days/week of vigorous physical activity 10+ minutes & -0.2577161 & 0.04647828 & 0.0000000294 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & 0.1215613 & 0.0287404 & 0.0000234073 & FE IVW & DF & 1.00 & confounder \\ 
  213 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-a-401 & Qualifications: CSEs or equivalent & 0.7547611 & 0.10537512 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & 0.2906741 & 0.0320150 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  214 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ukb-a-343 & Time from waking to first cigarette & -0.0450738 & 0.00898971 & 0.0000005333 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & 0.0471492 & 0.0110046 & 0.0000183135 & FE IVW & DF & 1.00 & confounder \\ 
  215 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & ubm-a-248 & IDP dMRI TBSS MD Splenium of corpus callosum & 0.0131288 & 0.00316940 & 0.0000343762 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & -0.0424392 & 0.0037402 & 0.0000000000 & FE IVW & DF & 1.00 & confounder \\ 
  216 & ukb-a-11 & Morning/evening person (chronotype) & ukb-d-20535 & Waking too early & prot-a-1442 & Immunoglobulin superfamily DCC subclass member 4 & 0.0053521 & 0.00042659 & 0.0000000000 & FE IVW & DF & 1.00 & -0.1333709 & 0.01969713 & 0.0000000000 & FE IVW & Tophits & 0.65 & 0.0149435 & 0.0030976 & 0.0000014054 & FE IVW & DF & 1.00 & confounder \\ 
   \hline
\hline
\caption{Confounder analysis of chronotype/trait relations using EipGraphDB. r1: exposure vs confounder; r2: exposure to outcome; r3: outcome and confounder.} 
\label{ConfounderAnalysis}
\end{longtable}
